Here is a quick summary, courtesy of Dan Perrin, of how the House Ways & Means Committee will mark up two HSA Bills.
Category: Cost of Healthcare
The New York Times (and the FDA) Does a Hatchet Job on Regenerative Medicine
The New York Times did a hatchet job on regenerative medicine. A visiting researcher at New York-Presbyterian/Weill Cornell Medical Center and other surgeons had performed numerous surgeries using BioBurst, a processed umbilical cord fluid, to help fuse together bones in minimally invasive surgeries. The fluid was administered to reduce healing time and reduce the need for more invasive back surgery.
Monday Links
- Health gains from key prescription drugs.
- Steve Henke, et. al., skewer a new Royal Society report on Covid-19.
- Health Affairs study: employers lack leverage to negotiate lower prices. Have they never heard of reference pricing?
- CDC: we are losing the battle against obesity. I thought we lost it a long time ago.
- Inequities at the doctors office: is it because the patients don’t speak up for themselves?
Saturday Links
- Patience is correlated with more success in school.
- “Aspirations cannot become law.” Sen. Bill Cassidy on Bernie Sanders’ latest health care proposal.
- Peter Nelson: How to make price transparency better.
- Is a female takeover of elite occupations taking place?
- Penn Wharton model: The federal government’s unfunded liability is $244.8 billion.